Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 1/2018

Content (20 Articles)

Review – Cancer Research

High-intensity exercise interventions in cancer survivors: a systematic review exploring the impact on health outcomes

Kellie Toohey, Kate Pumpa, Andrew McKune, Julie Cooke, Stuart Semple

Original Article – Cancer Research

The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer

Klaus Friese, Bernd Kost, Aurelia Vattai, Frederik Marmé, Christina Kuhn, Sven Mahner, Christian Dannecker, Udo Jeschke, Sabine Heublein

Open Access Original Article – Cancer Research

Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade

Akihiro Asai, Yasuyoshi Miyata, Kosuke Takehara, Shigeru Kanda, Shin-ichi Watanabe, Peter A. Greer, Hideki Sakai

Original Article – Cancer Research

A revision of the Tokuhashi revised score improves the prognostic ability in patients with metastatic spinal cord compression

Søren Schmidt Morgen, Sidsel Fruergaard, Martin Gehrchen, Sebastian Bjørck, Svend Aage Engelholm, Benny Dahl

Original Article – Cancer Research

Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression

Jianfeng Wang, Yunze Xu, Liangsong Zhu, Yun Zou, Wen Kong, Baijun Dong, Jiwei Huang, Yonghui Chen, Wei Xue, Yiran Huang, Jin Zhang

Original Article – Cancer Research

Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck

Till Sebastian Clauditz, Arne Böttcher, Henning Hanken, Kerstin Borgmann, Guido Sauter, Waldemar Wilczak, Tobias Grob, Adrian Münscher

Open Access Original Article – Cancer Research

Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16

Beata Biesaga, Anna Mucha-Małecka, Anna Janecka-Widła, Marta Kołodziej-Rzepa, Sława Szostek, Dorota Słonina, Aleksandra Kowalczyk, Krzysztof Halaszka, Marcin Przewoźnik

Original Article – Cancer Research

Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern

Yukiko Matsuo, Kazu Shiomi, Dai Sonoda, Masashi Mikubo, Masahito Naito, Yoshio Matsui, Tsutomu Yoshida, Yukitoshi Satoh

Original Article – Cancer Research

Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells

Kenichiro Ishii, Izumi Matsuoka, Shinya Kajiwara, Takeshi Sasaki, Manabu Miki, Manabu Kato, Hideki Kanda, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura

Review – Clinical Oncology

Cardiovascular effects of Hodgkin’s lymphoma: a review of literature

Aasems Jacob, Bragadheeswar Thyagarajan, Monisha Priyadarshini Kumar, Nasreen Shaikh, David Sharon

Original Article – Clinical Oncology

The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor

Akitoshi Takizawa, Koji Kawai, Takashi Kawahara, Takahiro Kojima, Satoru Maruyama, Nobuo Shinohara, Shusuke Akamatsu, Tomomi Kamba, Terukazu Nakamura, Osamu Ukimura, Ryosuke Jikuya, Takeshi Kishida, Kenichi Kakimoto, Kazuo Nishimura, Toru Harabayashi, Satoshi Nagamori, Shinichi Yamashita, Yoichi Arai, Yoshitomo Sawada, Noritoshi Sekido, Hidefumi Kinoshita, Tadashi Matsuda, Tohru Nakagawa, Yukio Homma, Hiroyuki Nishiyama

Original Article – Clinical Oncology

Lung cancer screening with MRI: results of the first screening round

Michael Meier-Schroers, Rami Homsi, Dirk Skowasch, Jens Buermann, Matthias Zipfel, Hans Heinz Schild, Daniel Thomas

Original Article – Clinical Oncology

Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies

C. Boglione-Kerrien, S. Picard, C. Tron, S. Nimubona, J.-P. Gangneux, S. Lalanne, F. Lemaitre, E. Bellissant, M.-C. Verdier, A. Petitcollin

Original Article – Clinical Oncology

Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety

Jia-yan Ni, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Xiong-ying Jiang, Dong Chen, Lin-feng Xu

Original Article – Clinical Oncology

Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?

Yiliang Zhang, Yuan Ma, Yuan Li, Xuxia Shen, Yongfu Yu, Yunjian Pan, Yang Zhang, Su Yu, Difan Zheng, Yue Zhao, Hong Hu, Yihua Sun, Yawei Zhang, Jiaqing Xiang, Haiquan Chen

Original Article – Clinical Oncology

Qualitative evaluation of mobile cancer apps with particular attention to the target group, content, and advertising

Cathleen Böhme, Marc Baron von Osthoff, Katrin Frey, Jutta Hübner

Letter to the Editor

Can checkpoint inhibitor therapy improve response to chemotherapy?

Michael Constantin Kirchberger, Bastian Schilling, Sebastian Haferkamp, Anja Bosserhoff, Gerold Schuler, Lucie Heinzerling

Open Access Correction

Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

Juan Luis Steegmann, Dolors Colomer, Maria-Teresa Gómez-Casares, Valentín García-Gutiérrez, Guillermo Ortí, Angel Ramírez-Payer, Eduardo Olavarria, Ferrán Vall-llovera, Pilar Giraldo, Eulogio Conde, Rolando Vallansot, Jose Luis López-Lorenzo, Luis Palomera, Alberto Álvarez-Larrán, Venancio Conesa, Guiomar Bautista, Laura Casas, Frank Giles, Andreas Hochhaus, Luis Felipe Casado-Montero

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.